IMpower132: PFS and Safety Results with 1L Atezolizumab plus Carboplatin/Cisplatin plus Pemetrexed in Stage IV Non-Squamous NSCLC
No Thumbnail Available
Identifiers
Date
2018-10-01
Authors
Papadimitrakopoulou, V.
Cobo, M.
Bordoni, R.
Dubray-Longeras, P.
Szalai, Z.
Ursol, G.
Novello, S.
Orlandi, F.
Ball, S.
Goldschmidt, J., Jr.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
atezolizumab, 1L NSCLC, chemotherapy